ArticleClinical journal of the American Society of Nephrology : CJASN2022

Safety of SGLT2 Inhibitors in CKD: Walking the Fine Line.

Mirela DobrePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.